HYPR · Hyperfine, Inc.
$0.84
+0.03 (+3.85%)
At close · Sep 3
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“The Company’s existing capital resources, including the net proceeds from the recent offerings described below, are expected to be sufficient to fund the Company’s operations for at least twelve months from the issuance date of these condensed consolidated financial statements. Unless and until the Company is able to generate a sufficient amount of revenue and generate positive operating cash flows, the Company expects to finance future cash needs through public and/or private offerings of equity securities and/or debt financings. If the Company is not able to obtain additional financing and/or substantially increase revenue from sales, in the longer term, it could result in a substantial doubt about the Company's ability to continue as a going concern. Management believes the net proceeds from the recent offerings, described under Note 9 – “Debt” and Note 10 – “Stockholders’ Equity”, and the Company’s anticipated revenue, provide sufficient liquidity to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$86.66M
Shares
106.05M
HYPR metrics
68 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.84
Market cap
$86.66M
Price action
19 metricsPrice change (1W)
-7.2%
Price change (30D)
-21.0%
Price change (3M)
-45.9%
Price change (6M)
-26.7%
Price change (YTD)
-17.7%
Price change (1Y)
-33.4%
Trailing year
Price change (5Y)
-91.9%
52-week high
$2.20
52-week low
$0.81
Change from 52-week high
-63.4%
Change from 52-week low
+0.0%
Annualized volatility
85.4%
Beta
2.4
RSI (14D)
26.7
Price vs SMA 50
-21.2%
Price vs SMA 200
-31.5%
Avg volume (3M)
969,019
Relative volume
0.5
Average dollar volume
$1.20M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
106.05M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.4×
reciprocal yield 29.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
5.2×
reciprocal yield 19.1%
P / book
2.4
reciprocal yield 42.4%
FCF yield
-31.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-40.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
51.4%
Operating margin
-203.3%
Trailing 12 months
Net margin
-210.8%
Gross profit (TTM)
$8.50M
Operating profit (TTM)
−$33.62M
Net income (TTM)
−$34.85M
Trailing 12 months
Diluted EPS (TTM)
$-0.37
FCF margin
-166.5%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+44.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$16.54M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+27.8%
Year over year · more shares
Revenue CAGR (3Y)
+25.8%
Revenue CAGR (5Y)
+115.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-94.8%
Return on assets
-55.3%
Debt / equity
0.4
Current ratio
6.2
EBITDA (TTM)
−$72.86M
Free cash flow (TTM)
−$27.53M
Quick ratio
5.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$30.22M
Latest balance sheet
Cash & equivalents
$43.46M
Total assets
$63.00M
Total debt
$13.23M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$27.07M
Capital expenditures (TTM)
$465,000
R&D (TTM)
$15.58M
SG&A (TTM)
—
Stock compensation (TTM)
$2.86M
R&D / revenue
94.2%
Stock compensation / revenue
17.3%
Ownership (13F)
3 metrics13F filers
82
13F filer change QoQ
+30
Institutional ownership
20.6%
Short interest
3 metricsShort interest
3.1%
Latest settlement · 5.7 days to cover
Days to cover
5.7d
Short-squeeze score
54 / 100
Insider activity
2 metricsNet insider buying (90D)
−$12,545
Insider-sentiment score
45 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1833769
CUSIP
44916K106
13F (30d)
67 filings
67 filers
Visit website
Investor relations